RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · Denton, TX · +84 more sites
Crohn's Disease clinical trials in Dallas, TX
13 recruiting crohn's disease studies with a site in Dallas, TX.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Dallas, TX · Fort Worth, TX · +48 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dallas, TX · Fort Worth, TX · Garland, TX · +58 more sites
RecruitingPhase 2NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Takeda
Bellaire, TX · Dallas, TX · Fort Worth, TX · +27 more sites
RecruitingPhase 2 / Phase 3NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Austin, TX · Carrollton, TX · Dallas, TX · +58 more sites
RecruitingPhase 3NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Carrollton, TX · Dallas, TX · Lubbock, TX · +36 more sites
RecruitingPhase 3NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Sanofi
Baytown, TX · Dallas, TX · Harlingen, TX · +122 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Cedar Park, TX · Dallas, TX · Houston, TX · +38 more sites
RecruitingPhase 2NCT06631586
Standardized Microbiota Transplant Therapy in Crohn's Disease
Sponsor: University of Minnesota
Dallas, TX · +2 more sites
RecruitingNot applicableNCT05230173
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Sponsor: Mayo Clinic
Dallas, TX · Houston, TX · +22 more sites
RecruitingNot applicableNCT03256240
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
Sponsor: Weill Medical College of Cornell University
Dallas, TX · Houston, TX · +4 more sites
RecruitingPhase 2NCT06456593
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Sponsor: Abivax S.A.
Austin, TX · Baytown, TX · Bellaire, TX · +40 more sites
RecruitingPhase 2NCT07113522
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Sponsor: Mirador Therapeutics, Inc.
Dallas, TX · Garland, TX · Georgetown, TX · +43 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.